<DOC>
	<DOC>NCT02821169</DOC>
	<brief_summary>Endoscopic sinus surgery (ESS) is a prevalent surgical procedure. It is required in many chronic rhinosinusitis for whom the medical treatment failed. In order to improve the postoperative management of patients treated with ESS, we aim to assess the analgesic action of local injection of ropivacaine in the nasal fossa.</brief_summary>
	<brief_title>Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain</brief_title>
	<detailed_description>A prospective randomized double blind placebo controlled study was designed. Local injection of ropivacaine or placebo was conducted at the end of the surgical procedure in both nasal fossa through endoscopic view in the sphenopalatine region. Pain was measured in the postoperative course with visual analogic scale in the recovery room and the rhinologic department.</detailed_description>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Ganglion Cysts</mesh_term>
	<mesh_term>Synovial Cyst</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>patients requiring endoscopic sinus surgery ASA score 1 or 2 patients with health care insurance approved consent any sinonasal malignant tumor renal failure, hepatic disorder, respiratory deficiency, cardiovascular diseases neurologic disorders alcohol or drugs addiction preoperative facial pain from an extranasal origin coagulation disorders antidepressive treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>sinus surgery</keyword>
	<keyword>sphenopalatin ganglion</keyword>
	<keyword>ropivacaine</keyword>
	<keyword>local anesthesia</keyword>
</DOC>